Advertisement
Product › Details
BIONDD technology
Next higher product group | oral drug delivery technology for biologics | |
Status | 2020-01-15 development existent | |
Organisation | Biograil ApS | |
Merck KGaA. (31/3/20). "Press Release: Merck Successfully Divests Allergopharma". Darmstadt.
Merck, a leading science and technology company, today completed the divestment of Allergopharma to Dermapharm Holding SE (“Dermapharm”) following regulatory approval and the satisfaction of other customary closing conditions. With the successful transaction closing, the Healthcare business sector will further sharpen its focus on the development of innovative medicines for difficult-to-treat diseases.
The allergy business of Merck in Europe was transferred to Dermapharm on March 31. The transfer of the Allergopharma business in China is planned for the second half of 2020. The two parties have agreed not to disclose the purchase price.
For more information, please contact
Friederike Segeberg
+49 6151 72-6328
Email
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
Record changed: 2023-07-10 |
Advertisement
More documents for oral drug delivery technology
- [1] Philip Morris International Inc.. (7/1/21). "Press Release: Philip Morris International Announces Agreement to Acquire Fertin Pharma". Lausanne....
- [2] Emisphere Technologies, Inc.. (11/6/20). "Press Release: Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion". Roseland, NJ....
- [3] Biograil ApS. (4/30/20). "Press Release: Biograil Announces Sanner Ventures Has Joined Investor Syndicate". Copenhagen....
- [4] High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables"....
- [5] Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen....
- [6] Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo....
- [7] Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo....
- [8] Medigene AG. (8/3/17). "Press Relase: Medigene Reports Results of First Six Months 2017". Planegg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top